Abstract: The invention relates to storage-stable prepregs (preimpregnated fibers) based on low-viscosity polyurethane systems having a very high characteristic number and flat fiber composite components (molded bodies; composite components) produced therefrom, which are obtained due to an impregnation method of fiber reinforced materials such as woven fabrics and fleece, and to a method for the production thereof.
Type:
Grant
Filed:
March 15, 2013
Date of Patent:
July 26, 2016
Assignee:
Bayer Intellectual Property GmbH
Inventors:
Florian Hupka, Marcel Schornstein, Dirk Wegener, Harald Rasselnberg
Abstract: The present invention relates to the use of triazinones such as triazinediones and triazinetriones for triazinetriones for the preparation of compositions for treating animals, in particular treating animals prophylactically, against parasitic protozoans, and to these compositions.
Abstract: The invention relates to the use of succinate dehydrogenase inhibitors, especially of fluopyram, for controlling Sclerotinia ssp., to a method for treating plants or plant parts for controlling Sclerotinia ssp. and to a method for treating seed for controlling Sclerotinia ssp. in the seed and in the plants which grow from the seed, by treating the seed with a succinate dehydrogenase inhibitor.
Type:
Application
Filed:
December 22, 2015
Publication date:
July 21, 2016
Applicant:
BAYER INTELLECTUAL PROPERTY GMBH
Inventors:
Ingo WETCHOLOWSKY, Heiko RIECK, Gilbert LABOURDETTE, Jose Augusto GERALDES
Abstract: The present application relates to novel 1-phenyl-1H-imidazo[1,2-b]pyrazole derivatives, to processes for their preparation, to their use for the treatment and/or prevention of diseases and to their use for preparing medicaments for the treatment and/or prevention of diseases, in particular angiogenic disorders and hyperproliferative disorders, where neovascularization plays a role, such as, for example, neoplastic disorders and tumor disorders. Such treatments can be carried out as monotherapy or else in combination with other medicaments or further therapeutic measures.
Abstract: The present invention relates to substituted benzimidazole compounds of general formula (I) in which R3, R5 and A are as defined in the claims, to methods of preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of a hyper-proliferative and/or angiogenesis disorder, as a sole agent or in combination with other active ingredients.
Type:
Grant
Filed:
March 28, 2012
Date of Patent:
July 12, 2016
Assignee:
Bayer Intellectual Property GmbH
Inventors:
Ulrich Klar, Marcus Koppitz, Duy Nguyen, Dirk Kosemund, Roland Neuhaus, Gerhard Siemeister
Abstract: Compounds of formula (I) a tautomer or stereoisomer thereof, or a salt thereof, wherein ring B and the imidazole to which it is fused, R4, R6 and R7 have the meanings as given in the description and the claims, are effective inhibitors of the Pi3K/Akt pathway.
Type:
Grant
Filed:
November 26, 2013
Date of Patent:
July 12, 2016
Assignee:
Bayer Intellectual Property GmbH
Inventors:
Swen Hölder, Armin Zülch, Thomas Bär, Thomas Maier, Astrid Zimmermann, Thomas Beckers, Volker Gekeler, Hemant Joshi, Yogesh Munot, Umesh Bhise, Sunil Chavan, Sachin Shivatare, Sarvesh Patel, Vikas Gore
Abstract: The present invention relates to: combinations of: component A: one or more omega-carboxyaryl-substituted diphenyl urea compounds of general formula (I), or a physiologically acceptable salt, solvate, hydrate or stereoisomer thereof; component B: one or more N-(2-arylamino)aryl sulfonamide compounds of general formula (II), or a physiologically acceptable salt, solvate, hydrate or stereoisomer thereof; and, optionally, component C: one or more further pharmaceutical agents; in which optionally some or all of the components are in the form of a pharmaceutical formulation which is ready for use to be administered simultaneously, concurrently, separately or sequentially. dependently of one another by the oral, intravenous, topical, local installations, intraperitoneal or nasal route; use of such combinations for the preparation of a medicament for the treatment or prophylaxis of a cancer; and a kit comprising such a combination.
Abstract: The present application relates to a liquid distributor and collector for columns for liquid chromatography with preferably round cross section, which is particularly suitable for columns with large diameter in relation to the packing height.
Type:
Grant
Filed:
August 26, 2005
Date of Patent:
July 5, 2016
Assignee:
Bayer Intellectual Property GmbH
Inventors:
Georg-Heinrich Klepp, Sebastian Böcker, Jochen Strube, Heinz Kansy, Hendrik Schmale
Abstract: The present invention provides Relaxin fusion polypeptides A-L-B with a non-wild type array of the Relaxin A-chain and Relaxin B-chain, wherein the A- and B-chains are connected by a linker peptide. The invention further provides Relaxin fusion polypeptides with extended half-life. Furthermore, the invention provides nucleic acid sequences encoding the foregoing fusion polypeptides, vectors containing the same, pharmaceutical compositions and medical use of such fusion polypeptides.
Type:
Grant
Filed:
June 29, 2012
Date of Patent:
July 5, 2016
Assignee:
BAYER INTELLECTUAL PROPERTY GMBH
Inventors:
Andreas Wilmen, Ulrich Haupts, Christoph Freiberg, Mark Trautwein, Lars Linden, Kirsten Leineweber, Hanna Tinel
Abstract: What is described are compounds of the general formula (I) and agrochemically acceptable salts thereof and their use in the field of crop protection.
Type:
Grant
Filed:
March 27, 2013
Date of Patent:
June 28, 2016
Assignee:
Bayer Intellectual Property GmbH
Inventors:
Klemens Minn, Michael Gerhard Hoffmann, Elmar Gatzweiler, Ines Heinemann, Isolde Haeuser-Hahn, Christopher Hugh Rosinger
Abstract: The present invention relates to a novel process for preparing cis-alkoxy-substituted spirocyclic phenylacetylamino acid esters and cis-alkoxy-substituted spirocyclic 1H-pyrrolidine-2,4-dione derivatives, and also to novel intermediates and starting materials which are produced and/or used in the process according to the invention.
Type:
Grant
Filed:
March 25, 2013
Date of Patent:
June 28, 2016
Assignee:
Bayer Intellectual Property GmbH
Inventors:
Taraneh Farida, Berndt Maiwald, Martin Littmann, Winfried Etzel, Rafael Warsitz, Nicolas Henck, Michael Esser
Abstract: The invention relates to a process for preparing aryl- and heteroarylacetic acids and derivatives thereof by reaction of aryl or heteroaryl halides with malonic diesters in the presence of a palladium catalyst, of one or more bases and optionally of a phase transfer catalyst. This process enables the preparation of a multitude of functionalized aryl- and heteroarylacetic acids and derivatives thereof, especially also the preparation of arylacetic acids with sterically demanding substituents.
Type:
Grant
Filed:
April 15, 2015
Date of Patent:
June 28, 2016
Assignee:
Bayer Intellectual Property GmbH
Inventors:
Thomas Himmler, Lukas J. Goossen, Felix Rudolphi, Bingrui Song
Abstract: Arylpyrrolidines of Formula (I): wherein each substituent is as defined in the specification, and use thereof as pesticides and animal parasite-controlling agents.
Abstract: The present invention relates to fungicidal N-cycloalkyl-N-[(cycloalkenylphenyl)methylene]carboxamide derivatives and their thiocarbonyl derivatives, their process of preparation and intermediate compounds for their preparation, their use as fungicides, particularly in the form of fungicidal compositions and methods for the control of phytopathogenic fungi of plants using these compounds or their compositions.
Type:
Grant
Filed:
March 25, 2013
Date of Patent:
June 28, 2016
Assignee:
BAYER INTELLECTUAL PROPERTY GMBH
Inventors:
Jurgen Benting, Philippe Desbordes, Pierre Cristau, Christophe Dubost, Mazen Es-Sayed, Stephanie Gary, Helene Lachaise, Philippe Rinolfi, Jan-Peter Schmidt, Tomoki Tsuchiya, Jean-Pierre Vors, Ulrike Wachendorff-Neumann
Abstract: The present invention relates to novel 5-halogenopyrazole(thio)carboxamides, their process of preparation, their use as fungicide active agents, particularly in the form of fungicide compositions, and methods for the control of phytopathogenic fungi, notably of plants, using these compounds or compositions.
Type:
Grant
Filed:
November 14, 2011
Date of Patent:
June 28, 2016
Assignee:
Bayer Intellectual Property GmbH
Inventors:
Jürgen Benting, Pierre-Yves Coqueron, Pierre Cristau, Peter Dahmen, Philippe Desbordes, Christophe Dubost, Stephanie Gary, Jörg Greul, Hiroyuki Hadano, Jean-Pierre Vors, Ulrike Wachendorff-Neumann
Abstract: Heteroarylpiperidine and -piperazine derivatives of the formula (I) in which the symbols RA1, RA2, X, Y, L1, L2, RB1, RB2, G, Q, p, R1, R2 and R10 are each as defined in the description, and salts, metal complexes and N-oxides of the compounds of the formula (I), and the use thereof for controlling phytopathogenic harmful fungi and processes for preparing compounds of the formula (I).
Type:
Grant
Filed:
December 21, 2012
Date of Patent:
June 28, 2016
Assignee:
Bayer Intellectual Property GmbH
Inventors:
Tomoki Tsuchiya, Pierre Wasnaire, Sebastian Hoffmann, Thomas Seitz, Stefan Hillebrand, Juergen Benting, Jan Peter Schmidt, Pierre Cristau
Abstract: The present invention relates to plant cells and plants which synthesize hyaluronan and to methods for preparing such plants, and also to methods for preparing hyaluronan with the aid of these plant cells or plants. Furthermore, the present invention relates to the use of plants for preparing hyaluronan and to food or feed which comprises hyaluronan.
Abstract: The present invention relates to the use of the ALS inhibitor herbicides for controlling unwanted vegetation in ALS inhibitor herbicide tolerant Brassica plants, more especially, the present invention relates to the use of ALS inhibitor herbicides for control of unwanted vegetation in Brassica growing areas which Brassica plants comprise non-transgenic mutations of their endogenous acetolactate synthase (ALS) genes I and III.
Type:
Grant
Filed:
May 4, 2012
Date of Patent:
June 21, 2016
Assignee:
Bayer Intellectual Property GmbH
Inventors:
Ruediger Hain, Gerhard Johann, Udo Bickers
Abstract: The invention relates to a method for stimulating the growth of the plants and/or improving the biomass production and/or increasing the carbon fixation by the plant comprising introducing into a plant cell, plant tissue or plant one or more nucleic acids, wherein the introduction of the nucleic acid(s) results inside the chloroplast of a de novo expression of one or more polypeptides having the enzymatic activity of a glycolate dehydrogenase made up from translationally fused subunits of bacterial multi-subunit glycolate dehydrogenase enzymes.
Type:
Grant
Filed:
February 3, 2011
Date of Patent:
June 21, 2016
Assignee:
BAYER INTELLECTUAL PROPERTY GMBH
Inventors:
Fritz Kreuzaler, Greta Noelke, Christoph Peterhaensel, Stefan Schillberg
Abstract: The present invention relates to active compound combinations, in particular within a fungicide composition, which comprises (A) ethaboxam and (B) fenamidone. Moreover, the invention relates to a method for curatively or preventively controlling the phytopathogenic fungi of plants or crops, to the use of a combination according to the invention for the treatment of seed, to a method for protecting a seed and not at least to the treated seed.
Type:
Grant
Filed:
January 30, 2013
Date of Patent:
June 21, 2016
Assignee:
Bayer Intellectual Property GmbH
Inventors:
Albert Schirring, Ulrike Wachendorff-Neumann, Sylvain Tafforeau, Marie-Pascale Latorse